AU1067795A - Use of lithium compounds in the treatment and prevention of alzheimer's disease - Google Patents

Use of lithium compounds in the treatment and prevention of alzheimer's disease

Info

Publication number
AU1067795A
AU1067795A AU10677/95A AU1067795A AU1067795A AU 1067795 A AU1067795 A AU 1067795A AU 10677/95 A AU10677/95 A AU 10677/95A AU 1067795 A AU1067795 A AU 1067795A AU 1067795 A AU1067795 A AU 1067795A
Authority
AU
Australia
Prior art keywords
alzheimer
disease
prevention
treatment
lithium compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10677/95A
Inventor
Karla Lehmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934340272 external-priority patent/DE4340272C1/en
Priority claimed from DE19934340273 external-priority patent/DE4340273A1/en
Application filed by Individual filed Critical Individual
Publication of AU1067795A publication Critical patent/AU1067795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of lithium compounds in the treatment and prevention of Alzheimer's disease. It also concerns a pharmaceutical agent containing at least one lithium compound and at least one acetylcholinesterase inhibitor in a fixed combination for use in the treatment and prevention of Alzheimer's disease.
AU10677/95A 1993-11-26 1994-11-26 Use of lithium compounds in the treatment and prevention of alzheimer's disease Abandoned AU1067795A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19934340272 DE4340272C1 (en) 1993-11-26 1993-11-26 Pharmaceutical composition for the optimised treatment of Alzheimer's disease and for preventing progression of this disease
DE4340273 1993-11-26
DE4340272 1993-11-26
DE19934340273 DE4340273A1 (en) 1993-11-26 1993-11-26 Medicament contg. lithium cpd.
PCT/EP1994/003921 WO1995014481A1 (en) 1993-11-26 1994-11-26 Use of lithium compounds in the treatment and prevention of alzheimer's disease

Publications (1)

Publication Number Publication Date
AU1067795A true AU1067795A (en) 1995-06-13

Family

ID=25931542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10677/95A Abandoned AU1067795A (en) 1993-11-26 1994-11-26 Use of lithium compounds in the treatment and prevention of alzheimer's disease

Country Status (5)

Country Link
EP (1) EP0730463B1 (en)
AT (1) ATE189391T1 (en)
AU (1) AU1067795A (en)
DE (1) DE59409129D1 (en)
WO (1) WO1995014481A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1000970A2 (en) 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho pharmaceutical composition for the treatment of Alzheimer's disease, process for its obtaining and use
WO2017215591A1 (en) * 2016-06-13 2017-12-21 Syneurx International (Taiwan) Corp. Use of lithium benzoate for treating central nervous system disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
DE3863678D1 (en) * 1987-04-27 1991-08-22 Efamol Holdings PHARMACEUTICAL PREPARATIONS CONTAINING LITHIUM SALTS.
HU207444B (en) * 1990-07-12 1993-04-28 Biorex Kutato Fejlesztoe Kft Method for producing therapeutical preparation suitable for treating alzheimer-disease
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine

Also Published As

Publication number Publication date
ATE189391T1 (en) 2000-02-15
DE59409129D1 (en) 2000-03-09
EP0730463B1 (en) 2000-02-02
WO1995014481A1 (en) 1995-06-01
EP0730463A1 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
EP0735870A4 (en) Use of pla 2? inhibitors as treatment for alzheimer's disease
AU4621893A (en) Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
HUP9903906A3 (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
WO1992011850A3 (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
CA2289717A1 (en) Novel therapy for constipation
WO1998020864A3 (en) Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases
UA41355C2 (en) Agent for treating neuro-aids
AU7397094A (en) Prevention and treatment of alzheimer's disease
MX9504023A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid.
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
AU2149797A (en) Therapeutic agents for asthma
EP0653208A3 (en) Pharmaceutical agents for treatment or prevention of sunburn.
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
HU9600725D0 (en) Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
IL119421A0 (en) Pharmaceutical compositions for the treatment of arrhythmia